Computational Biology Platform Company with a Pipeline of Experimentally-Validated New Drugs
Company's primary targets are cancer, the diseases of aging (e.g., Alzheimer's disease), and aging itself. Pursuing cosmetics also. Company owns (by granted patents) invented preclinical, and repurposed clinical, stage drugs. It has and is prosecuting longevity drug candidates. Professor George Church (of Harvard Medical School) is an Advisor.
How much is an extra decade of life worth to you? Make a bet on longevity science today.
